Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05278806 · ClinicalTrials.gov registry record · NA
Evaluating the Impact of an Equity Focused Dashboard and Clinical Support
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 10,766
- Enrollment target
NCT05278806: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05278806 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10,766 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (667% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05278806, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,766 participants
- Enrollment target
Study Summary
In this project, the impact of providing a practice-level equity dashboard that displays ambulatory quality outcome metrics stratified by race and language to primary care providers at Massachusetts General Hospital (MGH) will be evaluated. Provision of the dashboard data will be paired with additional clinical support focused on hypertension control among Black, Indigenous and People of Color (BIPOC) and patients with limited English proficiency (LEP). The investigators hypothesize that there will be a improvement in hypertension control (primary outcome), diabetes control and breast cancer screening (secondary outcomes) among Black, Indigenous and People of Color (BIPOC) and patients with limited English proficiency (LEP) in the intervention period compared to the control period.
Primary Outcome
* Blood pressure (BP) measured in the last 12 months AND last BP or average of last three BP readings (in the last 18 months) \<130/80 or * BP measured within past 6 months AND either the last or average of last three BP readings (in the last 18 months) meet one of the following criteria: * Age \< 60, BP ≤ 140/90 * Age ≥ 60 with Diabetes, BP ≤ 140/90; without Diabetes, BP ≤ 150/90 * Age ≥ 60, Diastolic BP \< 70, regardless of Systolic * On three or more anti-hypertensive medications fro
Interventions
- OTHER Equity Dashboard, Population Health Coordinator and Community Health Worker Support
- OTHER Equity Dashboard and Population Health Coordinator Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,766 participants |
| Start Date | 2022-03-24 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
What the finished NCT05278806 record still lists
NCT05278806 is an interventional study that assigns participants to a tested intervention. Its 10,766 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (667% higher).
The record links to 0 conditions, and to 2 interventions - of which Equity Dashboard, Population Health Coordinator and Community Health Worker Support is the first listed.
NCT05278806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05278806 about?
NCT05278806 is a clinical study titled "Evaluating the Impact of an Equity Focused Dashboard and Clinical Support". In this project, the impact of providing a practice-level equity dashboard that displays ambulatory quality outcome metrics stratified by race and language to primary care providers at Massachusetts General Hospital (MGH) will be evaluated. Provision of the dashboard data will be paired with additio...
What is the current status of trial NCT05278806?
This trial is currently completed. It is a NA study. The enrollment target is 10,766 participants. The study started on 2022-03-24. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT05278806?
The interventions under investigation include: Equity Dashboard, Population Health Coordinator and Community Health Worker Support (OTHER), Equity Dashboard and Population Health Coordinator Support (OTHER).
Who is sponsoring clinical trial NCT05278806?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05278806's enrollment target sits among peer trials
10,766 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- NCT06736951 · 10,890 participants · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
- NCT06081517 · 10,600 participants
Evaluating Disparities in Precision Oncology
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI